Last reviewed · How we verify

NCT05759585

Examining the Efficacy of Personalized Lifestyle Intervention in Individuals With Rheumatoid Arthritis

Status unknown NA Last updated 4 March 2024
What this trial tests

NA trial testing person-centered lifestyle intervention in Inflammatory Arthritis in 40 participants. Status unknown.

Timeline
1 March 2023
Primary endpoint
23 October 2023
30 March 2024

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 March 2023
Primary completion23 October 2023
Estimated completion30 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 65, any sex, with Inflammatory Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is aimed to examine the effects of person-centered lifestyle intervention on occupational performance, general health status, and quality of life in individuals with rheumatoid arthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Inflammatory Arthritis

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05759585.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing